Grown Rogue International (GRUSF) Return on Capital Employed (QoQ) (2011 - 2026)
Grown Rogue International (GRUSF) Return on Capital Employed (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -155,904.59 Bn |
| Dec 31, 2025 | -119.74 Mn |
| Sep 30, 2025 | 170.56 Mn |
| Sep 30, 2024 | -250.00 |
| Jun 30, 2024 | -1,897.00 |
| Apr 30, 2021 | 1.37 Mn |
| Jan 31, 2021 | -1.37 Mn |
| Oct 31, 2020 | -6,125.00 |
| Jan 31, 2019 | -44,919.00 |
| May 31, 2017 | 1,813.00 |
| Feb 28, 2017 | 1,833.00 |
| Aug 31, 2013 | 132.00 |
| Aug 31, 2012 | 86.00 |
| May 31, 2012 | -52.00 |
| Feb 29, 2012 | 38.00 |
| Nov 30, 2011 | -88.00 |